[Outcomes of childbearing and pregnancy in women with multiple sclerosis--a literature review].
In the last few years more studies indicated that although sclerosis multiplex frequently manifests in young adulthood, it should not be considered as contraindication for pregnancy in women affected with the disease. In fact, despite controversial literature data, pregnancy appears to be a protective factor to the disease without a harmful effect on the fetus. However, the use of immunomodulatory therapy during pregnancy needs a careful evaluation process and experts of this field may contribute to family happiness of the affected mother.
Szülészeti és Nőgyógyászati Klinika, Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ Szeged, Semmelweis u. 1., 6725.
Melinda
M
Vanya
D002585:Cesarean Section; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology / Q000523:psychology; D049590:Postpartum Period; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology / Q000517:prevention & control*; D011256:Pregnancy Outcome
D007166:Immunosuppressive Agents
caesarean section; császármetszés; immunmodulatory treatment during pregnancy; immunmoduláns terápia terhesség alatt; koraszülés; miscarriage; multiple sclerosis; pregnancy; preterm birth; sclerosis multiplex; terhesség; vetélés